loadpatents
name:-0.040271043777466
name:-0.02335000038147
name:-0.016355991363525
HUTCHISON MEDIPHARMA LIMITED Patent Filings

HUTCHISON MEDIPHARMA LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for HUTCHISON MEDIPHARMA LIMITED.The latest application filed is for "pharmaceutical preparation of fruquintinib and use thereof".

Company Profile
21.31.50
  • HUTCHISON MEDIPHARMA LIMITED - Shanghai N/A CN
  • Hutchison Medipharma Limited - Pilot Free Trade Zone CN
  • Hutchison Medipharma Limited -
  • Hutchison Medipharma Limited - Pudong Shanghai CN
  • Hutchison Medipharma Limited - Nassau BS
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Salts of a compound and the crystalline forms thereof
Grant 11,396,507 - Wu , et al. July 26, 2
2022-07-26
Pharmaceutical Preparation Of Fruquintinib And Use Thereof
App 20220125789 - Liu; Zhongzhou ;   et al.
2022-04-28
Heteroaryl Heterocyclic Compounds And Uses Thereof
App 20220125785 - DAI; Guangxiu ;   et al.
2022-04-28
Methods Of Using Surufatinib In Treating Advanced Pancreatic And Extra-pancreatic Neuroendocrine Tumors
App 20220073642 - SU; Wei-Guo ;   et al.
2022-03-10
Improved Method for the Manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazo- lo[4,5-b]pyrazine and polymorphic forms thereof
App 20220048904 - TURNER; Andrew Roy ;   et al.
2022-02-17
Cycloolefin Substituted Heteroaromatic Compounds And Their Use
App 20210363115 - Su; Wei-Guo ;   et al.
2021-11-25
Crystalline Forms Of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-n,2-dimethylbenzofuran-3-carboxamid- E
App 20210276983 - WU; Zhenping ;   et al.
2021-09-09
The Crystalline Forms Of A Compound
App 20210238180 - WU; Zhenping ;   et al.
2021-08-05
Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamid- e
Grant 11,046,674 - Wu , et al. June 29, 2
2021-06-29
Cycloolefin Substituted Heteroaromatic Compounds And Their Use
App 20210163426 - Su; Wei-Guo ;   et al.
2021-06-03
Certain Triazolopyridines And Triazolopyrazines, Compositions Thereof And Methods Of Use Therefor
App 20210154192 - Su; Wei-Guo ;   et al.
2021-05-27
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
Grant 10,946,014 - Su , et al. March 16, 2
2021-03-16
The Salts Of A Compound And The Crystalline Forms Thereof
App 20210047318 - WU; Zhenping ;   et al.
2021-02-18
Certain Triazolopyridines And Triazolopyrazines, Compositions Thereof And Methods Of Use Therefor
App 20200179377 - Dai; Guangxiu ;   et al.
2020-06-11
Cyrstalline Forms Of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-n,2-dimethylbenzofuran-3-carboxamid- E
App 20200140420 - WU; Zhenping ;   et al.
2020-05-07
Imidazopyridazine compounds and their use
Grant 10,611,777 - Su , et al.
2020-04-07
Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamid- e
Grant 10,519,142 - Wu , et al. Dec
2019-12-31
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
Grant 10,512,645 - Su , et al. Dec
2019-12-24
Method Of Treating Solid Tumors
App 20190276439 - QI; Chuan ;   et al.
2019-09-12
Pyrrolopyrimidine compounds and uses thereof
Grant 10,369,153 - Su , et al.
2019-08-06
Novel Imidazopyridazine Compounds And Their Use
App 20190127391 - Su; Wei-Guo ;   et al.
2019-05-02
Pyrrolopyrimidine Compounds And Uses Thereof
App 20190060319 - SU; Wei-Guo ;   et al.
2019-02-28
Imidazopyridazine compounds and their use
Grant 10,208,066 - Su , et al. Feb
2019-02-19
Pyrrolopyrimidine compounds and uses thereof
Grant 10,111,875 - Su , et al. October 30, 2
2018-10-30
Certain Triazolopyridines And Triazolopyrazines, Compositions Thereof And Methods Of Use Therefor
App 20180263977 - Su; Wei-Guo ;   et al.
2018-09-20
Substituted pyrido[3,4-b]pyrazines as Syk inhibitors
Grant 10,052,330 - Su , et al. August 21, 2
2018-08-21
Pharmaceutical Compositions And Use Thereof
App 20180153890 - Liu; Zhongzhou ;   et al.
2018-06-07
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
Grant 9,956,218 - Su , et al. May 1, 2
2018-05-01
Crystalline Forms of 6-((6,7-Dimethoxyquinazolin-4-yl)oxy)-N,2-Dimethylbenzofuran-3-Carboxamid- e
App 20170283399 - WU; Zhenping ;   et al.
2017-10-05
Novel Imidazopyridazine Compounds And Their Use
App 20170253618 - Su; Wei-Guo ;   et al.
2017-09-07
Pyrimidine and pyridine compounds and their usage
Grant 9,701,680 - Su , et al. July 11, 2
2017-07-11
Substituted Pyridopyrazines as Syk Inhibitors
App 20170152258 - SU; Wei-Guo ;   et al.
2017-06-01
Certain Triazolopyridines And Triazolopyrazines, Compositions Thereof And Methods Of Use Therefor
App 20170027934 - Su; Wei-Guo ;   et al.
2017-02-02
Substituted Pyridopyrazines As Novel Syk Inhibitors
App 20160324864 - SU; Wei-Guo ;   et al.
2016-11-10
Substituted pyrido[3,4-b]pyrazines as Syk inhibitors
Grant 9,434,726 - Su , et al. September 6, 2
2016-09-06
Pyrrolopyrimidine Compounds And Uses Thereof
App 20160228443 - SU; Wei-Guo ;   et al.
2016-08-11
Pyrrolopyrimidine compounds and uses thereof
Grant 9,346,810 - Su , et al. May 24, 2
2016-05-24
Novel Pyrimidine And Pyridine Compounds And Usage Thereof
App 20160052926 - SU; Wei-Guo ;   et al.
2016-02-25
Novel Pyrimidine And Pyridine Compounds And Their Usage
App 20160024021 - SU; Wei-Guo ;   et al.
2016-01-28
Substituted Pyridopyrazines as Syk Inhibitors
App 20160002221 - SU; Wei-Guo ;   et al.
2016-01-07
Certain Triazolopyridines And Triazolopyrazines, Compositions Thereof And Methods Of Use Therefor
App 20150368271 - Su; Wei-Guo ;   et al.
2015-12-24
Fused heteroaryls and their uses
Grant 9,181,264 - Su , et al. November 10, 2
2015-11-10
Novel Heteroaryl And Heterocycle Compounds, Compositions And Methods Thereof
App 20150307520 - SU; Wei-Guo ;   et al.
2015-10-29
Substituted Pyridopyrazines As Syk Inhibitors
App 20150307491 - SU; Wei-Guo ;   et al.
2015-10-29
Quinazoline compounds
Grant 9,168,253 - Zhang , et al. October 27, 2
2015-10-27
Novel Heteroaryl And Heterocycle Compounds, Compositions And Methods
App 20150291593 - Su; Wei-Guo ;   et al.
2015-10-15
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
Grant 8,987,269 - Su , et al. March 24, 2
2015-03-24
Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
Grant 8,946,249 - Su , et al. February 3, 2
2015-02-03
Compound, Certain Novel Forms Thereof, Pharmaceutical Compositions Thereof And Methods For Preparation And Use
App 20140200232 - SU; WEI-GUO ;   et al.
2014-07-17
Substituted Pyridopyrazines As Novel Syk Inhibitors
App 20140121200 - Su; Wei-Guo ;   et al.
2014-05-01
Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
Grant 8,658,658 - Su , et al. February 25, 2
2014-02-25
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
Grant 8,507,487 - Su , et al. August 13, 2
2013-08-13
Pyrimidinyl indole compounds
Grant 8,501,166 - Su , et al. August 6, 2
2013-08-06
Quinazoline Compounds
App 20130172373 - Zhang; Weihan ;   et al.
2013-07-04
Pyrimidinyl Indole Compounds
App 20130058892 - Su; Wei-Guo ;   et al.
2013-03-07
Decahydronaphthalene Compounds
App 20080139622 - Wang; Tao ;   et al.
2008-06-12
Costunolide Derivatives
App 20080051396 - Su; Weiguo ;   et al.
2008-02-28
Andrographolide and analogues as inhibitors of TNFalpha and IL-1beta expression
App 20050215628 - Yan, Xiaoqiang ;   et al.
2005-09-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed